GAMMA Investing LLC Sells 334 Shares of Azenta, Inc. (NASDAQ:AZTA)

GAMMA Investing LLC cut its stake in Azenta, Inc. (NASDAQ:AZTA) by 17.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,565 shares of the company’s stock after selling 334 shares during the period. GAMMA Investing LLC’s holdings in Azenta were worth $78,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Victory Capital Management Inc. lifted its stake in shares of Azenta by 31.7% in the 2nd quarter. Victory Capital Management Inc. now owns 26,220 shares of the company’s stock valued at $1,380,000 after purchasing an additional 6,318 shares during the period. Arizona State Retirement System lifted its position in Azenta by 2.0% during the second quarter. Arizona State Retirement System now owns 14,050 shares of the company’s stock valued at $739,000 after buying an additional 269 shares during the period. Acadian Asset Management LLC boosted its holdings in shares of Azenta by 118.2% during the 2nd quarter. Acadian Asset Management LLC now owns 5,196 shares of the company’s stock valued at $273,000 after buying an additional 2,815 shares in the last quarter. Texas Permanent School Fund Corp boosted its holdings in shares of Azenta by 9.3% during the 2nd quarter. Texas Permanent School Fund Corp now owns 53,321 shares of the company’s stock valued at $2,806,000 after buying an additional 4,516 shares in the last quarter. Finally, American Century Companies Inc. grew its position in shares of Azenta by 66.3% in the 2nd quarter. American Century Companies Inc. now owns 69,955 shares of the company’s stock worth $3,681,000 after buying an additional 27,882 shares during the period. 99.08% of the stock is owned by institutional investors.

Azenta Stock Performance

NASDAQ:AZTA opened at $51.70 on Friday. The firm has a market cap of $2.36 billion, a P/E ratio of -17.41 and a beta of 1.47. Azenta, Inc. has a fifty-two week low of $38.82 and a fifty-two week high of $69.16. The firm has a 50-day simple moving average of $47.24 and a two-hundred day simple moving average of $49.02.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.08. The company had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The firm’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.13 earnings per share. On average, equities research analysts predict that Azenta, Inc. will post 0.41 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Herman Cueto sold 712 shares of Azenta stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $40.07, for a total value of $28,529.84. Following the completion of the sale, the chief financial officer now directly owns 23,892 shares in the company, valued at approximately $957,352.44. This trade represents a 2.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William L. Cornog bought 12,500 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was acquired at an average cost of $39.60 per share, with a total value of $495,000.00. Following the transaction, the director now owns 14,755 shares in the company, valued at $584,298. The trade was a 554.32 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders sold 3,018 shares of company stock valued at $126,689. Corporate insiders own 10.62% of the company’s stock.

Analyst Upgrades and Downgrades

AZTA has been the subject of a number of recent research reports. Stephens reissued an “overweight” rating and set a $60.00 price target on shares of Azenta in a research report on Thursday, January 2nd. Needham & Company LLC lowered their target price on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Finally, Evercore ISI cut their price target on Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Azenta has a consensus rating of “Moderate Buy” and a consensus target price of $61.60.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.